Published in Expert Opin Biol Ther on May 01, 2015
Application of nucleoside analogues to liver transplant recipients with hepatitis B. World J Gastroenterol (2015) 0.75
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50
The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol (2005) 1.70
Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl (2014) 1.56
Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6. Hepatology (2010) 1.55
Treating hepatitis C in lower-income countries. N Engl J Med (2014) 1.52
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. Hepatology (2011) 1.49
Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy. Clin Gastroenterol Hepatol (2013) 1.48
Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci (2009) 1.34
Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology (2009) 1.32
Use of endoclips in the treatment of massive colonic diverticular bleeding. Gastrointest Endosc (2004) 1.25
Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial. Gastroenterology (2003) 1.20
Prevalence, risk factors, and disease knowledge of chronic hepatitis B infection in Vietnamese Americans in California. J Cancer Educ (2013) 1.03
Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. Hepatol Int (2010) 1.02
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. Antiviral Res (2010) 0.99
Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. Dig Dis Sci (2011) 0.98
Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies. Clin Gastroenterol Hepatol (2012) 0.96
High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy. J Clin Gastroenterol (2012) 0.95
Similar response to entecavir 0.5 and 1.0 mg in treatment-naïve chronic hepatitis B patients: a case-control study. Dig Dis Sci (2013) 0.92
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol (2008) 0.91
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Control (2012) 0.91
Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study. Dig Dis Sci (2012) 0.89
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine. J Clin Gastroenterol (2003) 0.88
Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma. Dig Dis Sci (2013) 0.87
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice. Eur J Gastroenterol Hepatol (2013) 0.87
Response to higher dose of entecavir 1.0 mg daily in patients with partial response to entecavir 0.5 mg daily. J Clin Gastroenterol (2013) 0.87
Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. J Gastroenterol Hepatol (2013) 0.86
Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice. J Clin Gastroenterol (2016) 0.86
Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. Am J Gastroenterol (2009) 0.85
Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders. Dig Dis Sci (2012) 0.85
Both HCV and HBV are major causes of liver cancer in Southeast Asians. J Immigr Minor Health (2013) 0.85
Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. Eur J Gastroenterol Hepatol (2014) 0.84
Current treatment guidelines for chronic hepatitis B and their applications. J Clin Gastroenterol (2014) 0.83
Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies. J Clin Gastroenterol (2014) 0.83
Prevalence of colorectal neoplasms in Asian Americans. Dig Dis Sci (2008) 0.82
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. Dig Dis Sci (2015) 0.82
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice. J Clin Gastroenterol (2016) 0.81
Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics. Dig Dis Sci (2013) 0.81
High proportion of hepatitis C virus in community Asian American patients with non-liver-related complaints. J Clin Gastroenterol (2013) 0.80
Isoniazid hepatotoxicity requiring liver transplantation. Dig Dis Sci (2014) 0.80
Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients. Dig Dis Sci (2013) 0.80
Less-established risk factors are common in Asian Americans with hepatitis C virus: a case-controlled study. Dig Dis Sci (2013) 0.80
High rate of complete viral suppression with combination therapy in patients with chronic hepatitis B and prior treatment failure. J Clin Gastroenterol (2011) 0.80
Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy. J Clin Gastroenterol (2015) 0.79
Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirin. Intervirology (2015) 0.79
Low proportion of Barrett's esophagus in Asian Americans. Am J Gastroenterol (2008) 0.79
Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases? Clin Infect Dis (2008) 0.78
Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. Hepatol Int (2009) 0.78
Safety and efficacy of entecavir in adefovir-experienced patients. J Gastroenterol Hepatol (2015) 0.78
Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States. Medicine (Baltimore) (2016) 0.77
Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings. J Clin Gastroenterol (2015) 0.77
Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy: A Matched Case-Cohort Study. J Clin Gastroenterol (2015) 0.77
Prophylactic clip application. Gastrointest Endosc (2003) 0.77
Low treatment rates in patients meeting guideline criteria in diverse practice settings. Dig Dis Sci (2014) 0.77
Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding. Gastrointest Endosc (2009) 0.77
Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers? Am J Gastroenterol (2002) 0.76
Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine (Baltimore) (2016) 0.75
Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis? Clin Gastroenterol Hepatol (2013) 0.75
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine (Baltimore) (2016) 0.75
Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine (Baltimore) (2017) 0.75
Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B. J Clin Gastroenterol (2017) 0.75
Validity of International Classification of Diseases, 10th Revision, Codes for Cirrhosis. Dig Dis (2020) 0.75
Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. J Clin Gastroenterol (2017) 0.75
Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients. Hepatol Int (2015) 0.75
Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy. J Clin Gastroenterol (2016) 0.75
Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy. Eur J Gastroenterol Hepatol (2015) 0.75
Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. Intervirology (2015) 0.75
Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1. Expert Opin Pharmacother (2015) 0.75
Management of Chronic Hepatitis B in Pregnancy. J Clin Gastroenterol (2017) 0.75
Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older. Eur J Gastroenterol Hepatol (2017) 0.75